State Of Wisconsin Investment Board Eagle Pharmaceuticals, Inc. Transaction History

State Of Wisconsin Investment Board

$37.8 Billion
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$4.63 - $15.21 $40,281 - $132,327	8,700 Added 67.97%	21,500 $112,000
Q3 2023 Nov 14, 2023	SELL	$15.21 - $22.88 $167,766 - $252,366	-11,030 Reduced 46.29%	12,800 $201,000
Q2 2023 Aug 14, 2023	BUY	$17.74 - $31.87 $25,722 - $46,211	1,450 Added 6.48%	23,830 $463,000
Q1 2023 May 15, 2023	SELL	$25.06 - $34.09 $250,900 - $341,309	-10,012 Reduced 30.91%	22,380 $634,000
Q4 2022 Feb 14, 2023	BUY	$24.98 - $39.77 $441,671 - $703,173	17,681 Added 120.19%	32,392 $946,000
Q3 2022 Nov 14, 2022	BUY	$26.42 - $47.12 $74,187 - $132,312	2,808 Added 23.59%	14,711 $389,000
Q2 2022 Aug 15, 2022	SELL	$41.26 - $51.35 $86,522 - $107,680	-2,097 Reduced 14.98%	11,903 $529,000
Q1 2021 May 17, 2021	SELL	$40.32 - $50.97 $64,512 - $81,552	-1,600 Reduced 10.26%	14,000 $584,000
Q4 2020 Feb 03, 2021	SELL	$41.72 - $51.34 $79,268 - $97,546	-1,900 Reduced 10.86%	15,600 $726,000
Q3 2020 Nov 16, 2020	BUY	$37.02 - $51.28 $125,868 - $174,352	3,400 Added 24.11%	17,500 $743,000
Q1 2020 May 06, 2020	SELL	$34.37 - $60.07 $10,311 - $18,021	-300 Reduced 2.08%	14,100 $649,000
Q2 2019 Aug 14, 2019	BUY	$46.61 - $58.45 $13,983 - $17,535	300 Added 2.13%	14,400 $802,000
Q1 2019 May 13, 2019	BUY	$38.66 - $51.82 $123,711 - $165,824	3,200 Added 29.36%	14,100 $712,000
Q4 2018 Feb 11, 2019	BUY	$36.72 - $67.73 $11,016 - $20,319	300 Added 2.83%	10,900 $439,000
Q2 2018 Aug 03, 2018	BUY	$51.25 - $76.62 $235,750 - $352,452	4,600 Added 76.67%	10,600 $802,000
Q3 2017 Nov 01, 2017	BUY	$46.62 - $60.36 $279,720 - $362,160	6,000	6,000 $358,000

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Of Wisconsin Investment Board, based on Form 13F filings with the SEC.

News

Stay updated on State Of Wisconsin Investment Board with notifications on news.

Account